Alvotech
Alvotech, officially known as Alvotech Holdings SA, is a prominent biopharmaceutical company headquartered in Luxembourg (LU). Founded in 2013, Alvotech focuses on the development and manufacturing of high-quality biosimilars, addressing the growing demand for affordable biologic therapies. With a strong operational presence in Europe and North America, the company has established itself as a key player in the biosimilars market. Alvotech's core offerings include a diverse portfolio of biosimilar products that are distinguished by their rigorous development processes and commitment to quality. The company has achieved significant milestones, including successful regulatory approvals and partnerships that enhance its market position. Recognised for its innovative approach, Alvotech continues to lead in the biopharmaceutical industry, striving to improve patient access to essential therapies.
DitchCarbon Score
How does Alvotech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Alvotech's score of 44 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Alvotech's reported carbon emissions
In 2024, Alvotech reported total carbon emissions of approximately 923,000 kg CO2e, with emissions distributed across various scopes. Specifically, Scope 1 emissions were about 39,800 kg CO2e, including 25,500 kg CO2e from fugitive emissions. Scope 2 emissions totalled approximately 231,000 kg CO2e, primarily from purchased electricity, which accounted for about 205,000 kg CO2e. The most significant contributor to their carbon footprint was Scope 3 emissions, which reached approximately 574,000 kg CO2e, with business travel alone contributing about 386,000 kg CO2e. In 2023, Alvotech's total emissions were reported at approximately 923,000 kg CO2e, with Scope 1 emissions at about 20,000 kg CO2e and Scope 2 emissions at approximately 209,000 kg CO2e. Scope 3 emissions for that year were around 555,000 kg CO2e, indicating a consistent trend in emissions across the years. Despite the substantial emissions figures, Alvotech has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or SBTi commitments. The company operates independently without cascading emissions data from a parent organisation, ensuring that its reported figures reflect its own operational impact. Overall, Alvotech's emissions profile highlights the need for ongoing assessment and potential strategies to mitigate its carbon footprint, particularly in Scope 3 emissions, which represent the largest share of its total emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 16,000 | 00,000 | 00,000 | 00,000 | 00,000 |
| Scope 2 | 202,000 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 3 | 261,000 | 000,000 | 000,000 | 000,000 | 000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Alvotech is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
